Rhythm Pharmaceuticals (RYTM) Change in Inventory (2022 - 2026)

Rhythm Pharmaceuticals (RYTM) has 5 years of Change in Inventory data on file, last reported at $3.1 million in Q1 2026.

• On a quarterly basis, Change in Inventory rose 436.7% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $10.0 million, a 7.62% decrease from a year earlier, with the FY2025 full-year figure at $7.5 million, down 26.12% from the prior year.
• Change in Inventory for Q1 2026 stood at $3.1 million, down from $4.9 million in the prior quarter.
• Over the last five years, Change in Inventory for RYTM reached as high as $4.9 million in Q4 2025 and fell as low as -$479000.0 in Q2 2025.
• Historically, Change in Inventory has averaged $1.8 million across 5 years, with a median of $1.6 million in 2023.
• Across the five-year window, Change in Inventory jumped 31800.0% in 2023 and tumbled 113.74% in 2025, its largest moves.
• Year by year, Change in Inventory stood at $1.2 million in 2022, then fell by 29.98% to $862000.0 in 2023, then surged by 462.18% to $4.8 million in 2024, then climbed by 1.67% to $4.9 million in 2025, then sank by 37.37% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Change in Inventory figures were $3.1 million in Q1 2026, $4.9 million in Q4 2025, and $2.5 million in Q3 2025.